Genetically Modified Cellular Therapies for Malignant Gliomas

Despite extensive preclinical research on immunotherapeutic approaches, malignant glioma remains a devastating disease of the central nervous system for which standard of care treatment is still confined to resection and radiochemotherapy. For peripheral solid tumors, immune checkpoint inhibition ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilian, Michael, Bunse, Theresa, Wick, Wolfgang, Platten, Michael, Bunse, Lukas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657496/
https://www.ncbi.nlm.nih.gov/pubmed/34884607
http://dx.doi.org/10.3390/ijms222312810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657496/
https://www.ncbi.nlm.nih.gov/pubmed/34884607
http://dx.doi.org/10.3390/ijms222312810

Ejemplares similares